Efficacy and Safety of Aficamten in Patients Guideline-Eligible for Septal Reduction Therapy in the FOREST-HCM Trial
Masri Ahmad, Naidu Srihari, Nassif Michael, Olivotto Iacopo, Oreziak Artur, Owens Anjali, Wever-pinzon Omar, Tower Rader Albree, Heitner Stephen, Kupfer Stuart, Malik Fady, Choudhury Lubna, Melloni Chiara, Meng Lixin, Wei Jenny, Saberi Sara, Garcia-pavia Pablo, Abraham Theodore, Barriales-villa Roberto, Bilen Ozlem, Elliott Perry, Hagege Albert, Nagueh Sherif